Reaction
Adenoma Benign reporting signals
As of the last recalculation, Adenoma Benign appears in 852 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is MOMETASONE (PRR 38.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Mometasone | 28 | 38.5 | 38.6 |
| Octreotide Acetate | 44 | 36.9 | 37.0 |
| Midazolam | 31 | 31.1 | 31.2 |
| Midazolam Hydrochloride | 32 | 30.1 | 30.2 |
| Haloperidol | 22 | 22.7 | 22.7 |
| Haloperidol Lactate | 22 | 22.3 | 22.3 |
| Valsartan Oral | 45 | 21.3 | 21.3 |
| Polatuzumab Vedotin | 7 | 17.7 | 17.7 |
| Lanreotide Acetate | 5 | 15.7 | 15.7 |
| Teduglutide | 8 | 14.6 | 14.6 |
| Ranolazine | 6 | 14.1 | 14.1 |
| Cinacalcet Hydrochloride | 6 | 3.2 | 3.2 |